Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: A systematic review

被引:86
作者
Klein, Jonathan [1 ]
Livergant, Jonathan [1 ]
Ringash, Jolie [1 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
关键词
Head and neck neoplasms; Squamous cell carcinoma; Radiotherapy; Chemoradiotherapy; Quality of life; Questionnaires; Systematic reviews; EUROPEAN-ORGANIZATION; FUNCTIONAL ASSESSMENT; HYPERFRACTIONATED RADIATION; UNRESECTABLE HEAD; CLINICAL-TRIALS; RESPONSE SHIFT; EORTC QLQ-C30; QUESTIONNAIRE; RADIOTHERAPY; VALIDATION;
D O I
10.1016/j.oraloncology.2014.01.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Health-related quality of life (HRQoL) is a subjective measure of patients' experience of disease and treatment. We systematically reviewed the literature to identify high quality manuscripts reporting HRQoL outcomes in adults with squamous cell carcinoma of the head and neck (HNSCC) treated with an organ-sparing curative regimen of radiation therapy with or without chemotherapy. Assessments were performed independently by two reviewers; a third reviewer resolved disputes. High quality reports were reviewed in detail to identify trends in HRQoL outcomes. MEDLINE and EMBASE searching yielded 276 distinct reports, plus 24 added via hand search. Of these, 53 met eligibility criteria and 18 were deemed high quality reports on the basis of a quality assessment tool. HRQoL declines after treatment but recovers to baseline levels, generally within 12 months. However, xerostomia-related HRQoL deficits may remain long-term. Combined chemoradiotherapy showed a trend toward worse HRQoL compared with RT alone. Intensity modulated radiotherapy (IMRT) yields better HRQoL compared with conventional or three-dimensional conformal radiotherapy. Baseline HRQoL may independently predict local-regional control and overall survival. Future research should incorporate HRQoL into phase III trials. However, adequate effort and journal space must be afforded to the HRQoL results of these studies to ensure proper reporting methods are followed, allowing clinicians to incorporate HRQoL into patient counseling and clinical decision making. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:254 / 262
页数:9
相关论文
共 66 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma [J].
Abdel-Wahab, M ;
Abitbol, A ;
Lewin, A ;
Troner, M ;
Hamilton, K ;
Markoe, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04) :359-366
[3]   Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG [J].
Au, Heather-Jane ;
Ringash, Jolie ;
Brundage, Michael ;
Palmer, Michael ;
Richardson, Harriet ;
Meyer, Ralph M. .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (02) :119-128
[4]   Monitoring population health for Healthy People 2020: evaluation of the NIH PROMISA® Global Health, CDC Healthy Days, and satisfaction with life instruments [J].
Barile, John P. ;
Reeve, Bryce B. ;
Smith, Ashley Wilder ;
Zack, Matthew M. ;
Mitchell, Sandra A. ;
Kobau, Rosemarie ;
Cella, David F. ;
Luncheon, Cecily ;
Thompson, William W. .
QUALITY OF LIFE RESEARCH, 2013, 22 (06) :1201-1211
[5]   Quality of life in head and neck cancer patients:: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire -: H&N35 [J].
Bjordal, K ;
Hammerlid, E ;
Ahlner-Elmqvist, M ;
de Graeff, A ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
de Leeuw, JRJ ;
Fayers, PM ;
Jannert, M ;
Westin, T ;
Kaasa, S .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :1008-1019
[6]   Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site [J].
Blanchard, Pierre ;
Baujat, Bertrand ;
Holostenco, Victoria ;
Bourredjem, Abderrahmane ;
Baey, Charlotte ;
Bourhis, Jean ;
Pignon, Jean-Pierre .
RADIOTHERAPY AND ONCOLOGY, 2011, 100 (01) :33-40
[7]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[8]   Standards are needed for quality of life clinical trials [J].
Bottomley, A ;
Efficace, F ;
Fayers, PM .
BRITISH MEDICAL JOURNAL, 2002, 324 (7346) :1156-1156
[9]   Health-related quality of life by disease and socio economic group in the general population in Sweden [J].
Burström, K ;
Johannesson, M ;
Diderichsen, F .
HEALTH POLICY, 2001, 55 (01) :51-69
[10]   Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension [J].
Calvert, Melanie ;
Blazeby, Jane ;
Altman, Douglas G. ;
Revicki, Dennis A. ;
Moher, David ;
Brundage, Michael D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08) :814-822